Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163Nabil F Saba, Yael Flamand, Derrick T Lin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Bone cancerJ Sybil Biermann, Douglas R Adkins, Mark Agulnik, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2010
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignanciesPaula M Fracasso, Kerry J Williams, Ronald C Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2023
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck CancerMiriam T Jacobs, Pamela Wong, Alice Y Zhou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2017
NCCN Guidelines Insights: Bone Cancer, Version 2.2017J Sybil Biermann, Warren Chow, Damon R Reed, et al.
Thyroid : Official Journal of the American Thyroid Association|June 16, 2020
An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid CancerKeith C Bible, Michael E Menefee, Chia-Chi Josh Lin, et al.
Nature Communications|September 29, 2025
In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy targetCong Fu, Robert Saddawi-Konefka, Jordan M Chinai, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
High-avidity TCR signaling induces a distinct KLR-positive exhaustion state in human tumor-infiltrating CD8 T cells associated with immunotherapy responseRiley D Z Mullins, Jesse M Zaretsky, Thomas F Barrett, et al.
Science Immunology|September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancerGiacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Pageof 14